SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > March 2009

« Previous month Next month »

SDTech and Malvern team up on process optimisation

31-Mar-2009 -  Custom micronisation and milling firm SDTech has bolted on particle size analysis to its suite of drug industry offerings through a new collaboration with UK analysis specialist Malvern Instruments. ...

News in brief

Winpak wins Reynolds’ Packaging license race

31-Mar-2009 - Canada’s Winpak has gained an exclusive license to use Reynolds Packaging’s manufacturing know-how in the production of packaging for the drug and healthcare industries.

Deal bags Flugen a vaccine delivery micro-device

31-Mar-2009 -  Flugen has secured the exclusive rights to Ratio’s novel vaccine delivery technology, which is a disposable micro-device that it claims can improve efficacy and compliance.

Pall’s Lego-like Stax system attracts biotechs

31-Mar-2009 -  Pall’s Stax single-use depth filter attracted interest from a “number of biotechnology companies” at Interphex, according to director of marketing Ian Sellick who explained how the system can save space,...

SAFC’s Kansas culture site goes animal component-free

30-Mar-2009 -  Operations at SAFC Biosciences’ facility in Kansas, US have been made animal component-free (ACF) under a division-wide strategy to keep pace with customer demands and changing regulations. 

Indian plants offer new source for Tamiflu precursor

30-Mar-2009 -  Researchers believe they have found “more promising” sources of shikimic acid, a precursor in the production of Tamiflu, shortages of which have previously caused bottlenecks in producing the bird flu...

Target’s packaging failed to increase compliance; study

30-Mar-2009 -  A US pharmacy’s attempt to implement simpler packaging that clearly communicates information to patients has failed to improve compliance, according to a study.

News in brief

Lundbeck rumours boost Elan’s share price

30-Mar-2009 -  Speculation that drugmaker Elan is a takeover target for Denmark’s Lundbeck boosted the Irish drugmakers share price 11 per cent on Friday last week. 

Global Federation will “speak as one”, says IPEC Europe chair

26-Mar-2009 -  The International Pharmaceutical Excipient Council (IPEC) has unveiled plans to set up a worldwide Federation later this year to address the increasingly global excipient supply chain.

News in brief

Novartis bids for greater share of Indian subsidiary

26-Mar-2009 -  Novartis is looking to buy an additional 39 per cent of its majority-owned subsidiary Novartis India for around 4.4bn rupees ($87m), or 351 rupees per share.

Flexibility is key for processing sector says Millipore

26-Mar-2009 -  Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.

Grassley and Torti face-off over whistleblowers

26-Mar-2009 -  Senator Grassley has raised concerns that an email by acting Commissioner Torti to FDA employees could be viewed as an attempt to suppress whistleblowers following recent releases of internal agency...

Hospira’s “Project Fuel” will cut 1,400 jobs

25-Mar-2009 -  US drug delivery specialist Hospira will reduce its workforce by around 10 per cent, or 1,400 employees, over the next 24 months as part of its $140m (€104m) a year...

GSK may move for Botox maker Allergan

25-Mar-2009 -  The pharmaceutical rumour mill is still spinning with the latest speculation that UK drug major GSK is interested in Botox manufacturer Allergan causing the US firm’s share price to leap...

News in brief

Merck ramps up biologics spending in Ireland

25-Mar-2009 -  Merck & Co is investing an additional €20m ($27m) in its biologics plant in Carlow, Ireland just weeks after it unveiled plans to create a “powerful biologics presence” through its...

Pharma mega mergers a boon for Patheon's restructuring service, says CEO

25-Mar-2009 -  The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler. ...

Snapshot of technologies at Interphex 2009

24-Mar-2009 -  St Patrick’s Day celebrations weren’t the only thing bringing people together in New York last week as the pharmaceutical manufacturing and outsourcing industries gathered at the Jacob K Javits convention...

Vetter launches VPI subsidiary

24-Mar-2009 -  Vetter Pharma-Fertigung (VPF), a specialist provider of pre-filled injection systems, has formed a new subsidiary, Vetter Pharma International (VPI) to take charge of sales, marketing and customer services. 

News in brief

UK and Australia clear Ranbaxy’s Paonta Sahib plant

24-Mar-2009 -  Regulators in the UK and Australia have issued GMP certificates for Ranbaxy Laboratories' Paonta Sahib plant after a joint inspection deemed manufacturing practices were up to code.

Watson recalls batch oversized arrhythmia drug

24-Mar-2009 - Watson Pharmaceuticals has voluntarily withdrawn one lot of its arrhythmia drug propafenone HCl in the US after the tablets were found to contain slightly higher levels of the drug’s API....

MDRNA signs deal with second Swiss major

24-Mar-2009 - US RNA interference (RNAi) specialist MDRNA has signed a non-exclusive licensing deal granting Swiss drug giant Novartis access to its liposomal siRNA delivery technology platform.

HP claims it can cut costs for 80% flexo printing

24-Mar-2009 -  Hewlett-Packard has made its high-volume digital press commercially available, which it claims can cut waste, warehousing and environmental impact compared to analogue printing.  

Packaging feeling effects of downturn, says Alcan pharmaceutical packaging president

23-Mar-2009 - Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will...

Skin care firm Stiefel considers $4bn sale

23-Mar-2009 -  Dermatology drug specialist Stiefel Laboratories may be looking for a Big Pharma buyer according to various media reports.

Inhaled insulin from conception to...success?

23-Mar-2009 -  With MannKind approaching US regulatory filing for Afresa in-PharmaTechnologist presents its exclusive interactive timeline spanning the rise, fall and possible resurrection of inhaled insulin treatments, covering Pfizer’s Exubera and all...

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products